A retrospective comparative exploratory study on two Methylentetrahydrofolate Reductase (MTHFR) polymorphisms in esophagogastric cancer: the A1298C MTHFR polymorphism is an independent prognostic factor only in neoadjuvantly treated gastric cancer patients

Peer Review reports

Original Submission
8 Jul 2013	Submitted	Original manuscript
13 Aug 2013	Reviewed	Reviewer Report - Wei Tang
20 Sep 2013	Reviewed	Reviewer Report - Anna Tomezzoli
6 Nov 2013	Author responded	Author comments - Susanne Blank
Resubmission - Version 2
6 Nov 2013	Submitted	Manuscript version 2
Publishing
26 Nov 2013	Editorially accepted
3 Feb 2014	Article published	10.1186/1471-2407-14-58

Back to article page